Skip to main content
Premium Trial:

Request an Annual Quote

Harvard /Brigham and Women's Picks LabVantage Sapphire for Legacy LIMS Phaseout

NEW YORK (GenomeWeb News) - LabVantage Solutions said today that the Channing Laboratory at Brigham and Women's Hospital and Harvard Medical School has licensed its Sapphire BioBanking Solution.
The Channing Laboratory is focused on the investigation of bacteriology, chronic disease epidemiology, and virology.
The lab will deploy Sapphire in its Respiratory Epidemiology Genotyping Laboratory as part of a multi-phase project to replace “significant portions” of its existing laboratory information management systems and other internally developed software packages, LabVantage said.
LabVantage said that the lab has been using in-house LIMS for genotyping research and has now chosen to switch to a commercial product for its biorepository and sample-tracking system.
"We were primarily seeking a solution for our biorepository needs, but quickly found that many of our internally built laboratory systems and process would be tied to the biorepository processes," Scott Weiss, principal investigator for the Channing Laboratory, said in a statement. "We needed a solution that would provide state-of-the-art biorepository management and that would also replace our legacy systems with standardized solutions.”

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.